Clinical Trials
2 trialsNCT06965309 2026-02-12
Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG)
Shenzhen MagicRNA Biotechnology Co., Ltd
Phase NA Terminated
NCT00004682 2015-03-25
Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
FDA Office of Orphan Products Development
Phase NA Terminated